{"id":1548,"date":"2020-07-14T02:17:40","date_gmt":"2020-07-14T02:17:40","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=1548"},"modified":"2023-08-29T18:02:01","modified_gmt":"2023-08-29T18:02:01","slug":"neuroscientific-hails-potential-breakthrough-early-emtinb-study-results","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=1548","title":{"rendered":"\u5728\u65e9\u671fEmtinB\u7814\u7a76\u7ed3\u679c\u4e4b\u540e\uff0cNeuroScientific\u8fce\u6765\u4e86\u6f5c\u5728\u7684\u7a81\u7834"},"content":{"rendered":"<p><a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=NSB&amp;lang=cn\">NeuroScientific Biopharmaceuticals (ASX: NSB)<\/a>\u53d1\u8868\u4e86\u5176\u5148\u5bfc\u5316\u5408\u7269EmtinB\u5728\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7(MS)\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u7684\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\u3002<\/p>\n<p>\u5b8c\u6574\u7684\u62a5\u544a\u5c06\u88ab\u8fd9\u4e2a\u6708\u5e95\u51fa\u7248,\u867d\u7136\u6839\u636e\u516c\u53f8\u7684\u9996\u5e2d\u6267\u884c\u5b98Matthew Liddelow\u65e9\u671f\u7ed3\u679c\u5df2\u7ecf\u8868\u660e\u201c\u6f5c\u5728\u7a81\u7834\u201d\u5e76\u786e\u8ba4EmtinB,\u4e8b\u5b9e\u4e0a,\u9ad3\u9798\u5f62\u6210\u663e\u8457\u589e\u52a0\u2014\u2014\u7ade\u76f8\u53d1\u5c55\u7684\u4e00\u4e2a\u5173\u952e\u6307\u6807\u7684\u6709\u6548\u6cbb\u7597\u8870\u5f31\u7684\u72b6\u6001\u3002<\/p>\n<p>\u8fd9\u9879\u57fa\u4e8e\u6cd5\u56fd\u7684\u7814\u7a76\u89c2\u5bdf\u4e86EmtinB\u5728\u591a\u53d1\u6027\u786c\u5316\u75c7\u6a21\u578b\u4e2d\u7684\u5f71\u54cd\uff0c\u5176\u4e2d\u8be5\u5316\u5408\u7269\u7684\u6cbb\u7597\u6f5c\u529b\u4e0e\u5df2\u4e0a\u5e02\u7684\u9886\u5148\u836f\u7269Copaxone\u8fdb\u884c\u4e86\u5bf9\u6bd4\uff0c\u540e\u8005\u662f\u76ee\u524d\u5168\u7403\u7528\u4e8e\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7\u7684\u514d\u75ab\u8c03\u8282\u836f\u7269\u3002<\/p>\n<p>\u7ed3\u679c\u8868\u660e\uff0c\u5f53\u6d53\u5ea6\u4e3a30\u03bcg\/\u6beb\u5347\u300160\u03bcg\/\u6beb\u5347\u3001120\u03bcg\/\u6beb\u5347\u548c150\u03bcg\/\u6beb\u5347\u65f6\uff0cEmtinB\u201c\u663e\u8457\u589e\u52a0\u201d\u9ad3\u9798\u7684\u5f62\u6210\u3002\u6b64\u5916\uff0c\u4e0eCopaxone\u76f8\u6bd4\uff0cEmtinB\u5728150\u03bcg\/ml\u6d53\u5ea6\u65f6\u589e\u52a0\u4e8630%\u4ee5\u4e0a\u7684\u9ad3\u9798\u5f62\u6210\uff0c\u5728120\u03bcg\/ml\u65f6\u589e\u52a0\u4e8625%\u4ee5\u4e0a\u7684\u9ad3\u9798\u5f62\u6210\u3002<\/p>\n<h2>\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7<\/h2>\n<p>\u591a\u53d1\u6027\u786c\u5316\u75c7\u662f\u4e00\u79cd\u6162\u6027\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\uff0c\u60a3\u8005\u7684\u514d\u75ab\u7cfb\u7edf\u4f1a\u9519\u8bef\u5730\u653b\u51fb\u5468\u56f4\u795e\u7ecf\u7ea4\u7ef4\u7684\u9ad3\u9798\u3002<\/p>\n<p>\u8fd9\u79cd\u75be\u75c5\u901a\u5e38\u4f1a\u5f71\u54cd\u5927\u8111\u548c\u810a\u9ad3\uff0c\u5bfc\u81f4\u5e7f\u6cdb\u7684\u6f5c\u5728\u75c7\u72b6\uff0c\u5305\u62ec\u89c6\u529b\u53d7\u635f\u3001\u80a2\u4f53\u4e0d\u81ea\u4e3b\u8fd0\u52a8\u4ee5\u53ca\u611f\u89c9\u548c\u5e73\u8861\u4e27\u5931\u3002\u8fd9\u79cd\u60c5\u51b5\u662f\u9ad8\u5ea6\u8870\u5f31\uff0c\u8fdb\u884c\u6027\u548c\u6ca1\u6709\u6cbb\u6108\u3002<\/p>\n<p>\u5728\u4ee5\u524d\u7684\u4e34\u5e8a\u7814\u7a76\u4e2d\uff0cCopaxone\u88ab\u8bc1\u660e\u53ef\u4ee5\u51cf\u5c11\u590d\u53d1\u7684\u9891\u7387\uff0c\u4f46\u5e76\u6ca1\u6709\u51cf\u5c11\u6b8b\u75be\u7684\u8fdb\u5c55\u3002<\/p>\n<p>\u8be5\u836f\u7269\u76ee\u524d\u88ab\u8ba4\u4e3a\u662f\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7\u7684\u4e3b\u8981\u836f\u7269\uff0c\u56e0\u6b64\u4ea7\u751f\u4e86\u5927\u7ea640\u4ebf\u7f8e\u5143(57\u4ebf\u6fb3\u5143)\u7684\u5cf0\u503c\u9500\u552e\u6536\u5165\u3002<\/p>\n<p>\u7136\u800c\uff0c\u9274\u4e8e\u8fd9\u79cd\u836f\u7269\u53ea\u80fd\u89e3\u51b3\u90e8\u5206\u95ee\u9898\uff0c\u800c\u4e14\u4e0d\u80fd\u51cf\u5c11\u6b8b\u75be\u7684\u8fdb\u5c55\uff0c\u4e00\u4e9b\u5236\u836f\u516c\u53f8\u6b63\u5728\u7ade\u76f8\u5f00\u53d1\u7b2c\u4e00\u79cd\u80fd\u626d\u8f6c\u5c40\u9762\u3001\u5e2e\u52a9\u75c5\u4eba\u5eb7\u590d\u7684\u836f\u7269\uff0c\u800c\u4e0d\u4ec5\u4ec5\u662f\u7f13\u89e3\u4e25\u91cd\u75c7\u72b6\u3002<\/p>\n<p>\u6839\u636e\u5e02\u573a\u8c03\u67e5\uff0c\u5305\u62ec\u836f\u7269\u9500\u552e\u603b\u989d\u5728\u5185\uff0c\u76ee\u524dMS\u5e02\u573a\u4ef7\u503c\u4f30\u8ba1\u8d85\u8fc7200\u4ebf\u7f8e\u5143(290\u4ebf\u6fb3\u5143)\uff0c\u5168\u7403\u6709230\u4e07\u60a3\u8005\u60a3\u6709\u8fd9\u79cd\u75be\u75c5\u3002<\/p>\n<p>Liddelow\u5148\u751f\u8bf4:\u201c\u867d\u7136\u6211\u4eec\u4e4b\u524d\u5728MS\u6a21\u578b\u4e2d\u8868\u660eEmtinB\u53ef\u4ee5\u79ef\u6781\u5f71\u54cd\u9ad3\u5f62\u6210\u5c11\u7a81\u80f6\u8d28\u7ec6\u80de\u7684\u589e\u6b96\uff0c\u8fd9\u4e9b\u7ed3\u679c\u8fdb\u4e00\u6b65\u8bc1\u660eEmtinB\u663e\u8457\u589e\u52a0\u9ad3\u9798\u7684\u5b9e\u9645\u5f62\u6210\u3002\u201d<\/p>\n<p>\u201c\u8fd9\u4e9b\u7ed3\u679c\u4ee3\u8868\u4e86\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7\u7684\u4e00\u4e2a\u6f5c\u5728\u7a81\u7834\uff0c\u56e0\u4e3a\u76ee\u524d\u8fd8\u6ca1\u6709\u5f97\u5230\u6279\u51c6\u7684\u6cbb\u7597\u836f\u7269\u80fd\u591f\u8ba9\u60a3\u8005\u5728\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u4e2d\u518d\u751f\u9ad3\u78f7\u8102\uff0c\u201d\u4ed6\u8865\u5145\u9053\u3002<\/p>\n<p>\u65e9\u76d8\uff0cNeuroscientific\u7684\u80a1\u4ef7\u4e0a\u6da822.5%\uff0c\u81f30.245\u6fb3\u5143\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NeuroScientific Biopharmaceuticals (ASX: NSB)\u53d1\u8868\u4e86\u5176\u5148\u5bfc\u5316\u5408\u7269EmtinB\u5728\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7(MS)\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u7684\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\u3002 \u5b8c\u6574\u7684\u62a5\u544a\u5c06\u88ab\u8fd9\u4e2a\u6708\u5e95\u51fa\u7248,\u867d\u7136\u6839\u636e\u516c\u53f8\u7684\u9996\u5e2d\u6267\u884c\u5b98Matthew Liddelow\u65e9\u671f\u7ed3\u679c\u5df2\u7ecf\u8868\u660e\u201c\u6f5c\u5728\u7a81\u7834\u201d\u5e76\u786e\u8ba4EmtinB,\u4e8b\u5b9e\u4e0a,\u9ad3\u9798\u5f62\u6210\u663e\u8457\u589e\u52a0\u2014\u2014\u7ade\u76f8\u53d1\u5c55\u7684\u4e00\u4e2a\u5173\u952e\u6307\u6807\u7684\u6709\u6548\u6cbb\u7597\u8870\u5f31\u7684\u72b6\u6001\u3002 \u8fd9\u9879\u57fa\u4e8e\u6cd5\u56fd\u7684\u7814\u7a76\u89c2\u5bdf\u4e86EmtinB\u5728\u591a\u53d1\u6027\u786c\u5316\u75c7\u6a21\u578b\u4e2d\u7684\u5f71\u54cd\uff0c\u5176\u4e2d\u8be5\u5316\u5408\u7269\u7684\u6cbb\u7597\u6f5c\u529b\u4e0e\u5df2\u4e0a\u5e02\u7684\u9886\u5148\u836f\u7269Copaxone\u8fdb\u884c\u4e86\u5bf9\u6bd4\uff0c\u540e\u8005\u662f\u76ee\u524d\u5168\u7403\u7528\u4e8e\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7\u7684\u514d\u75ab\u8c03\u8282\u836f\u7269\u3002 \u7ed3\u679c\u8868\u660e\uff0c\u5f53\u6d53\u5ea6\u4e3a30\u03bcg\/\u6beb\u5347\u300160\u03bcg\/\u6beb\u5347\u3001120\u03bcg\/\u6beb\u5347\u548c150\u03bcg\/\u6beb\u5347\u65f6\uff0cEmtinB\u201c\u663e\u8457\u589e\u52a0\u201d\u9ad3\u9798\u7684\u5f62\u6210\u3002\u6b64\u5916\uff0c\u4e0eCopaxone\u76f8\u6bd4\uff0cEmtinB\u5728150\u03bcg\/ml\u6d53\u5ea6\u65f6\u589e\u52a0\u4e8630%\u4ee5\u4e0a\u7684\u9ad3\u9798\u5f62\u6210\uff0c\u5728120\u03bcg\/ml\u65f6\u589e\u52a0\u4e8625%\u4ee5\u4e0a\u7684\u9ad3\u9798\u5f62\u6210\u3002 \u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7 \u591a\u53d1\u6027\u786c\u5316\u75c7\u662f\u4e00\u79cd\u6162\u6027\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\uff0c\u60a3\u8005\u7684\u514d\u75ab\u7cfb\u7edf\u4f1a\u9519\u8bef\u5730\u653b\u51fb\u5468\u56f4\u795e\u7ecf\u7ea4\u7ef4\u7684\u9ad3\u9798\u3002 \u8fd9\u79cd\u75be\u75c5\u901a\u5e38\u4f1a\u5f71\u54cd\u5927\u8111\u548c\u810a\u9ad3\uff0c\u5bfc\u81f4\u5e7f\u6cdb\u7684\u6f5c\u5728\u75c7\u72b6\uff0c\u5305\u62ec\u89c6\u529b\u53d7\u635f\u3001\u80a2\u4f53\u4e0d\u81ea\u4e3b\u8fd0\u52a8\u4ee5\u53ca\u611f\u89c9\u548c\u5e73\u8861\u4e27\u5931\u3002\u8fd9\u79cd\u60c5\u51b5\u662f\u9ad8\u5ea6\u8870\u5f31\uff0c\u8fdb\u884c\u6027\u548c\u6ca1\u6709\u6cbb\u6108\u3002 \u5728\u4ee5\u524d\u7684\u4e34\u5e8a\u7814\u7a76\u4e2d\uff0cCopaxone\u88ab\u8bc1\u660e\u53ef\u4ee5\u51cf\u5c11\u590d\u53d1\u7684\u9891\u7387\uff0c\u4f46\u5e76\u6ca1\u6709\u51cf\u5c11\u6b8b\u75be\u7684\u8fdb\u5c55\u3002 \u8be5\u836f\u7269\u76ee\u524d\u88ab\u8ba4\u4e3a\u662f\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7\u7684\u4e3b\u8981\u836f\u7269\uff0c\u56e0\u6b64\u4ea7\u751f\u4e86\u5927\u7ea640\u4ebf\u7f8e\u5143(57\u4ebf\u6fb3\u5143)\u7684\u5cf0\u503c\u9500\u552e\u6536\u5165\u3002 \u7136\u800c\uff0c\u9274\u4e8e\u8fd9\u79cd\u836f\u7269\u53ea\u80fd\u89e3\u51b3\u90e8\u5206\u95ee\u9898\uff0c\u800c\u4e14\u4e0d\u80fd\u51cf\u5c11\u6b8b\u75be\u7684\u8fdb\u5c55\uff0c\u4e00\u4e9b\u5236\u836f\u516c\u53f8\u6b63\u5728\u7ade\u76f8\u5f00\u53d1\u7b2c\u4e00\u79cd\u80fd\u626d\u8f6c\u5c40\u9762\u3001\u5e2e\u52a9\u75c5\u4eba\u5eb7\u590d\u7684\u836f\u7269\uff0c\u800c\u4e0d\u4ec5\u4ec5\u662f\u7f13\u89e3\u4e25\u91cd\u75c7\u72b6\u3002 \u6839\u636e\u5e02\u573a\u8c03\u67e5\uff0c\u5305\u62ec\u836f\u7269\u9500\u552e\u603b\u989d\u5728\u5185\uff0c\u76ee\u524dMS\u5e02\u573a\u4ef7\u503c\u4f30\u8ba1\u8d85\u8fc7200\u4ebf\u7f8e\u5143(290\u4ebf\u6fb3\u5143)\uff0c\u5168\u7403\u6709230\u4e07\u60a3\u8005\u60a3\u6709\u8fd9\u79cd\u75be\u75c5\u3002 Liddelow\u5148\u751f\u8bf4:\u201c\u867d\u7136\u6211\u4eec\u4e4b\u524d\u5728MS\u6a21\u578b\u4e2d\u8868\u660eEmtinB\u53ef\u4ee5\u79ef\u6781\u5f71\u54cd\u9ad3\u5f62\u6210\u5c11\u7a81\u80f6\u8d28\u7ec6\u80de\u7684\u589e\u6b96\uff0c\u8fd9\u4e9b\u7ed3\u679c\u8fdb\u4e00\u6b65\u8bc1\u660eEmtinB\u663e\u8457\u589e\u52a0\u9ad3\u9798\u7684\u5b9e\u9645\u5f62\u6210\u3002\u201d \u201c\u8fd9\u4e9b\u7ed3\u679c\u4ee3\u8868\u4e86\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7\u7684\u4e00\u4e2a\u6f5c\u5728\u7a81\u7834\uff0c\u56e0\u4e3a\u76ee\u524d\u8fd8\u6ca1\u6709\u5f97\u5230\u6279\u51c6\u7684\u6cbb\u7597\u836f\u7269\u80fd\u591f\u8ba9\u60a3\u8005\u5728\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u4e2d\u518d\u751f\u9ad3\u78f7\u8102\uff0c\u201d\u4ed6\u8865\u5145\u9053\u3002 \u65e9\u76d8\uff0cNeuroscientific\u7684\u80a1\u4ef7\u4e0a\u6da822.5%\uff0c\u81f30.245\u6fb3\u5143\u3002<\/p>\n","protected":false},"author":5,"featured_media":8594,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[17],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u5728\u65e9\u671fEmtinB\u7814\u7a76\u7ed3\u679c\u4e4b\u540e\uff0cNeuroScientific\u8fce\u6765\u4e86\u6f5c\u5728\u7684\u7a81\u7834<\/title>\n<meta name=\"description\" content=\"NeuroScientific Biopharmaceuticals (ASX: NSB)\u53d1\u8868\u4e86\u5176\u5148\u5bfc\u5316\u5408\u7269EmtinB\u5728\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7(MS)\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u7684\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u5728\u65e9\u671fEmtinB\u7814\u7a76\u7ed3\u679c\u4e4b\u540e\uff0cNeuroScientific\u8fce\u6765\u4e86\u6f5c\u5728\u7684\u7a81\u7834\" \/>\n<meta property=\"og:description\" content=\"NeuroScientific Biopharmaceuticals (ASX: NSB)\u53d1\u8868\u4e86\u5176\u5148\u5bfc\u5316\u5408\u7269EmtinB\u5728\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7(MS)\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u7684\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/neuroscientific-hails-potential-breakthrough-early-emtinb-study-results\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-14T02:17:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:02:01+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/07\/NeuroScientific-Biopharmaceuticals-ASX-NSB-Copaxone-myelin-formation-MS-model-EmtinB-Multiple-sclerosis.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"\u5728\u65e9\u671fEmtinB\u7814\u7a76\u7ed3\u679c\u4e4b\u540e\uff0cNeuroScientific\u8fce\u6765\u4e86\u6f5c\u5728\u7684\u7a81\u7834\" \/>\n<meta name=\"twitter:description\" content=\"NeuroScientific Biopharmaceuticals (ASX: NSB)\u53d1\u8868\u4e86\u5176\u5148\u5bfc\u5316\u5408\u7269EmtinB\u5728\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7(MS)\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u7684\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/07\/NeuroScientific-Biopharmaceuticals-ASX-NSB-Copaxone-myelin-formation-MS-model-EmtinB-Multiple-sclerosis.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/neuroscientific-hails-potential-breakthrough-early-emtinb-study-results\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/neuroscientific-hails-potential-breakthrough-early-emtinb-study-results\/\",\"name\":\"\u5728\u65e9\u671fEmtinB\u7814\u7a76\u7ed3\u679c\u4e4b\u540e\uff0cNeuroScientific\u8fce\u6765\u4e86\u6f5c\u5728\u7684\u7a81\u7834\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-07-14T02:17:40+00:00\",\"dateModified\":\"2023-08-29T18:02:01+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"NeuroScientific Biopharmaceuticals (ASX: NSB)\u53d1\u8868\u4e86\u5176\u5148\u5bfc\u5316\u5408\u7269EmtinB\u5728\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7(MS)\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u7684\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/neuroscientific-hails-potential-breakthrough-early-emtinb-study-results\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/neuroscientific-hails-potential-breakthrough-early-emtinb-study-results\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/neuroscientific-hails-potential-breakthrough-early-emtinb-study-results\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5728\u65e9\u671fEmtinB\u7814\u7a76\u7ed3\u679c\u4e4b\u540e\uff0cNeuroScientific\u8fce\u6765\u4e86\u6f5c\u5728\u7684\u7a81\u7834\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u5728\u65e9\u671fEmtinB\u7814\u7a76\u7ed3\u679c\u4e4b\u540e\uff0cNeuroScientific\u8fce\u6765\u4e86\u6f5c\u5728\u7684\u7a81\u7834","description":"NeuroScientific Biopharmaceuticals (ASX: NSB)\u53d1\u8868\u4e86\u5176\u5148\u5bfc\u5316\u5408\u7269EmtinB\u5728\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7(MS)\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u7684\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"\u5728\u65e9\u671fEmtinB\u7814\u7a76\u7ed3\u679c\u4e4b\u540e\uff0cNeuroScientific\u8fce\u6765\u4e86\u6f5c\u5728\u7684\u7a81\u7834","og_description":"NeuroScientific Biopharmaceuticals (ASX: NSB)\u53d1\u8868\u4e86\u5176\u5148\u5bfc\u5316\u5408\u7269EmtinB\u5728\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7(MS)\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u7684\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/neuroscientific-hails-potential-breakthrough-early-emtinb-study-results\/","og_site_name":"smallcapsCN","article_published_time":"2020-07-14T02:17:40+00:00","article_modified_time":"2023-08-29T18:02:01+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/07\/NeuroScientific-Biopharmaceuticals-ASX-NSB-Copaxone-myelin-formation-MS-model-EmtinB-Multiple-sclerosis.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"\u5728\u65e9\u671fEmtinB\u7814\u7a76\u7ed3\u679c\u4e4b\u540e\uff0cNeuroScientific\u8fce\u6765\u4e86\u6f5c\u5728\u7684\u7a81\u7834","twitter_description":"NeuroScientific Biopharmaceuticals (ASX: NSB)\u53d1\u8868\u4e86\u5176\u5148\u5bfc\u5316\u5408\u7269EmtinB\u5728\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7(MS)\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u7684\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/07\/NeuroScientific-Biopharmaceuticals-ASX-NSB-Copaxone-myelin-formation-MS-model-EmtinB-Multiple-sclerosis.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/neuroscientific-hails-potential-breakthrough-early-emtinb-study-results\/","url":"https:\/\/smallcapscn.x5view.co\/neuroscientific-hails-potential-breakthrough-early-emtinb-study-results\/","name":"\u5728\u65e9\u671fEmtinB\u7814\u7a76\u7ed3\u679c\u4e4b\u540e\uff0cNeuroScientific\u8fce\u6765\u4e86\u6f5c\u5728\u7684\u7a81\u7834","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-07-14T02:17:40+00:00","dateModified":"2023-08-29T18:02:01+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"NeuroScientific Biopharmaceuticals (ASX: NSB)\u53d1\u8868\u4e86\u5176\u5148\u5bfc\u5316\u5408\u7269EmtinB\u5728\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\u75c7(MS)\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u7684\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/neuroscientific-hails-potential-breakthrough-early-emtinb-study-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/neuroscientific-hails-potential-breakthrough-early-emtinb-study-results\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/neuroscientific-hails-potential-breakthrough-early-emtinb-study-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"\u5728\u65e9\u671fEmtinB\u7814\u7a76\u7ed3\u679c\u4e4b\u540e\uff0cNeuroScientific\u8fce\u6765\u4e86\u6f5c\u5728\u7684\u7a81\u7834"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1548"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1548"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1548\/revisions"}],"predecessor-version":[{"id":8593,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1548\/revisions\/8593"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/8594"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1548"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1548"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}